6-80273199-C-T
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM2PP2PP3_StrongPP5_Very_Strong
The NM_183050.4(BCKDHB):c.1016C>T(p.Ser339Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000155 in 1,613,312 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. S339S) has been classified as Likely benign.
Frequency
Consequence
NM_183050.4 missense
Scores
Clinical Significance
Conservation
Publications
- maple syrup urine disease type 1BInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, G2P, Myriad Women’s Health
- maple syrup urine diseaseInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- classic maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- intermediate maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- intermittent maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- thiamine-responsive maple syrup urine diseaseInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| BCKDHB | NM_183050.4 | c.1016C>T | p.Ser339Leu | missense_variant | Exon 9 of 10 | ENST00000320393.9 | NP_898871.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BCKDHB | ENST00000320393.9 | c.1016C>T | p.Ser339Leu | missense_variant | Exon 9 of 10 | 1 | NM_183050.4 | ENSP00000318351.5 | ||
| BCKDHB | ENST00000356489.9 | c.1016C>T | p.Ser339Leu | missense_variant | Exon 9 of 11 | 1 | ENSP00000348880.5 | |||
| BCKDHB | ENST00000468520.1 | n.*9C>T | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152102Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00 AC: 0AN: 250844 AF XY: 0.00
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1461210Hom.: 0 Cov.: 30 AF XY: 0.0000138 AC XY: 10AN XY: 726900 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152102Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74288 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Maple syrup urine disease Pathogenic:5
A Heterozygous Missense variant c.1016C>T in Exon 9 of the BCKDHB gene that results in the amino acid substitution p.Ser339Leu was identified. The observed variant has a minor allele frequency of 0.00003 in and genomes and is novel in gnomAD exomes. The severity of the impact of this variant on the protein is medium, based on the effect of the protein and REVEL score. Rare Exome Variant Ensemble Learner (REVEL) is an ensembl method for predicting the pathogenicity of missense variants based on a combination of scores from 13individual tools: MutPred, FATHMM v2.3, VEST 3.0, PolyPhen-2, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP++, SiPhy, phyloP, and phastCons. The REVEL score for an individual missense variant can range from 0 to 1, with higher scores reflecting greater likelihood that the variant is disease-causing. ClinVar has also classified this variant as Pathogenic [Variant ID: 96563]. This variant has previously been reported for maple syrup urine disease by Ali, Ernie Zuraida, and Lock-Hock Ngu., 2018. Experimental studies have shown that this missense change affects BCKDHB function by Wynn, R. Max, et al., 2001. For these reasons this variant has been classified as Likely Pathogenic. -
Variant summary: BCKDHB c.1016C>T (p.Ser339Leu) results in a non-conservative amino acid change located in the Transketolase, C-terminal domain (IPR033248) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 250844 control chromosomes (gnomAD). c.1016C>T has been reported in the literature in multiple individuals affected with Maple Syrup Urine Disease (e.g. Wynn_2001, Gorzelany_2009, Bashyam_2012). These data indicate that the variant is very likely to be associated with disease. At least one publication reported experimental evidence evaluating an impact on protein function, and demonstrated complete absence of activity in patient derived fibroblasts, and in a bacterial expression system (Wynn_2001). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014, partly without evidence for independent evaluation, and classified the variant as pathogenic (n=2) or likely pathogenic (n=1). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
- -
This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 339 of the BCKDHB protein (p.Ser339Leu). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individual(s) with BCKDHB-related conditions (PMID: 11448970, 22593002, 30228974; Invitae). This variant is also known as p.Ser289Leu. ClinVar contains an entry for this variant (Variation ID: 96563). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt BCKDHB protein function with a negative predictive value of 80%. Experimental studies have shown that this missense change affects BCKDHB function (PMID: 11448970). For these reasons, this variant has been classified as Pathogenic. -
Maple syrup urine disease type 1B Pathogenic:4
- -
- -
- -
- -
not provided Pathogenic:1
- -
Maple syrup urine disease type 1A Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at